Trials / Unknown
UnknownNCT05310955
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia
Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.
Detailed description
Shen-based Qigong exercise is a new kind of health-care Qigong exercise based on the theory of traditional Chinese medicine, aiming at the characteristics of schizophrenia. In this study, a randomized controlled trial was conducted to observe the rehabilitation effect of this new exercise on residual symptoms of schizophrenic patients. Questionnaire, test and other experimental materials were used to evaluate the intervention effect of 12-week shen-based Qigong exercise on psychiatric symptoms, cognitive function, quality of life and social function of schizophrenic patients. At the same time, the related physical function and cardiac function indexes were used to evaluate the physical and cardiac rehabilitation effects of the exercise on patients from the aspects of "body" and "heart", so as to verify whether Qigong exercise has the effects of adjusting body and heart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | daily rehabilitation interventions | including Naikan therapy, Morita therapy, group art therapy, group painting therapy |
| OTHER | shen-based Qigong exercise | a 12-week intervention of shen-based Qigong exercise : exercise 5 days a week, about 30 minutes a day |
Timeline
- Start date
- 2022-08-16
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2022-04-05
- Last updated
- 2022-10-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05310955. Inclusion in this directory is not an endorsement.